Shop by goal
Popular compounds
Research resources
Recently viewed
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Shop by region
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io
BPC+TB 10mg Combo
Choose pack size
Select strength and vial count — prices shown for the selected SKU
Lab-direct quality — full packs or single-vial samples
Every batch ships straight from the lab that synthesises it — sealed, tamper-evident, and HPLC-verified to >99% purity . Buying direct means you pay the lab-direct rate on every vial, with nothing stacked on top.
Order a full sealed 10-vial research pack for a complete study supply, or add a single-vial sample alongside your pack to trial a new compound first. Same lab, same batch, same verified purity — scaled to whatever your research needs.
What It's Researched For
In plain terms, this is the same two-peptide repair blend at double strength. Here is what that looks like across the research.
Tissue-repair research
BPC-157 and TB-500 dominate the published peptide repair literature and are almost always studied together.
Angiogenesis
BPC-157 is studied for blood-vessel formation signalling, notably through the VEGFR2 pathway.
Cell migration
TB-500 binds actin monomers, which is central to how cells move into a repair site.
Longer protocols
Twice the peptide per vial, so one reconstitution covers more of an extended research schedule.
Overview
In short: The double-strength BPC+TB blend — BPC-157 and TB-500 at 10 mg each, 20 mg of total peptide per vial, in the same fixed 1:1 ratio as the 5mg combo.
Key research facts
Research use only. These points summarise lab themes, not human outcomes.
This is the higher-strength version of the BPC+TB blend. The composition is identical in kind and ratio — BPC-157 and TB-500 at 1:1 — but each vial carries 10 mg of each rather than 5 mg, for 20 mg of total peptide. The practical difference is protocol length: one reconstitution covers roughly twice as much of a research schedule, which matters when the alternative is opening and reconstituting a second vial partway through.
The compounds themselves are unchanged. BPC-157 is a synthetic pentadecapeptide (GEPPPGKPADDAGLV) derived from a sequence in human gastric juice, studied principally for angiogenic signalling through the VEGFR2 pathway. TB-500 is the synthetic analogue of the actin-binding domain of thymosin beta-4, studied for actin monomer sequestration and cell migration. They approach tissue-repair research from genuinely different mechanistic directions, which is why they are studied together rather than interchangeably.
One point of care with the higher strength: it changes concentration, not protocol. A 20 mg vial reconstituted in the same volume as a 10 mg vial is twice as concentrated, so reconstitution volume should be adjusted rather than the research schedule. As with the 5mg combo, no study has characterised the two compounds administered as a fixed blend. Supplied as research-grade lyophilised powder for in-vitro and preclinical work only; nothing on this page is medical advice.
Mechanism of Action
The blend has no combined mechanism — it is two independent compounds sharing a vial. BPC-157 is studied for angiogenic signalling through VEGFR2, TB-500 for actin monomer binding and cell migration. Doubling the strength changes concentration, not pharmacology.
Everything mechanistic that applies to the 5mg combo applies here — the compounds and their ratio are identical, and no controlled study has characterised them administered together as a fixed blend. The one addition specific to this format is a handling consideration rather than a pharmacological one. Researchers moving from the 5mg to the 10mg vial sometimes carry over a reconstitution volume, which doubles the concentration per unit volume and silently doubles delivered mass unless the draw volume is halved. That is an arithmetic trap, not a pharmacological property, but it is the most likely source of error when switching strengths. The underlying asymmetry between the components also persists: the animal literature commonly describes TB-500 with a longer effective window than BPC-157, so a fixed blend still forces one administration frequency on two compounds whose separate protocols often differ.
Common Questions People Are Asking
What is in the BPC+TB 10mg Combo?
Each vial contains BPC-157 10 mg and TB-500 10 mg — 20 mg of total peptide, in a fixed 1:1 ratio across every vial in the pack. Both components are also available individually, so the blend can be benchmarked against its parts. It is supplied for laboratory research only and is not for human use.
How does this differ from the 5mg combo?
Strength only. The 5mg combo carries BPC-157 5 mg and TB-500 5 mg — 10 mg total. This one doubles both to 10 mg each, for 20 mg total, at the same 1:1 ratio. The compounds are identical; the higher-strength vial simply covers more of a protocol per reconstitution.
Do I reconstitute it the same way as the 5mg vial?
Not if you want the same concentration. A 20 mg vial reconstituted in the volume you would use for a 10 mg vial is twice as concentrated, which doubles delivered mass per unit volume. Either double the diluent volume or halve the draw volume. This is the most common error when switching between the two strengths.
Do BPC-157 and TB-500 work better together?
No study has shown that. They are combined because their research domains overlap, not because synergy has been demonstrated — no pharmacokinetic, interaction or comparative efficacy data exists for the pair administered together. Their mechanisms are genuinely distinct: angiogenic signalling for BPC-157, actin binding for TB-500.
How should the combo be stored?
Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because the vial contains two compounds with different stability characteristics, use it within the validated window for the batch rather than extrapolating from either component alone.
Where can I buy BPC+TB 10mg Combo?
Right here — BPC+TB 10mg Combo is supplied directly by New-U Research Compounds on this page. Every batch is independently third-party tested to >99% HPLC purity with a batch-linked Certificate of Analysis, supplied as lyophilised research-grade material, and shipped direct from source worldwide in discreet, tracked packaging. Strictly for laboratory research use only — not for human use.
How much does BPC+TB 10mg Combo cost?
BPC+TB 10mg Combo pricing is shown live on this page, per pack size — 10-vial research packs as standard, with single-vial sample options on selected compounds. Larger vial strengths lower the per-mg cost, every order includes the batch Certificate of Analysis, and shipping is free on orders over $300.
Is BPC+TB 10mg Combo third-party tested?
Yes. Every BPC+TB 10mg Combo batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC. Every order ships with its COA, and current batch certificates are published on our COA page.
How do I buy BPC+TB 10mg Combo?
Add the BPC+TB 10mg Combo pack size you need to your cart and check out: enter your shipping details, then choose your payment method — cryptocurrency or card — on the next step. Every order ships with its batch Certificate of Analysis (COA). BPC+TB 10mg Combo is supplied strictly for laboratory research use only, not for human or veterinary use.
What payment methods can I use to buy BPC+TB 10mg Combo?
At checkout you can pay by cryptocurrency (BTC, ETH, SOL, LTC, USDC, USDT and more) or by card, each handled by a dedicated secure payment provider. You choose your method after confirming your order.
How fast is shipping, and do you ship worldwide?
Yes — we ship worldwide in discreet, unmarked, temperature-stable, tracked packaging. Delivery typically takes 6–14 business days, and shipping is free on orders over $300.
Is it legal to buy BPC+TB 10mg Combo?
In the United States, BPC+TB 10mg Combo is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.
Pharmacokinetics
Evidence Tier
Overall: Tier 3: Anecdotal / self-report
The blend itself has no evidence base: no pharmacokinetic, safety or efficacy study has examined BPC-157 and TB-500 administered together as a fixed combination, and no interaction data exists. Both components have substantial but predominantly rodent literatures with no controlled human efficacy data. Neither has regulatory approval — BPC-157's July 2026 FDA compounding-committee review concerned 503A Bulks List eligibility, which is not an approval. Supplied as unapproved laboratory material.
Source References & Further Reading
Last reviewed: 29 July 2026 · New-U Research Compounds
Key Characteristics
Specifications
About the BPC+TB 10mg Combo: Double-Strength Research Blend Guide
This is the higher-strength member of the BPC+TB pair. Composition and ratio are identical to the 5mg combo — BPC-157 and TB-500 at 1:1 — but each vial carries 10 mg of each rather than 5 mg, for 20 mg of total peptide. The reason to choose it is protocol length: a single reconstitution covers about twice as much of a research schedule, which avoids opening a second vial partway through and the handling variance that introduces.
The science is the same as the 5mg format. BPC-157 is a pentadecapeptide derived from a gastric protective sequence, unusually stable in gastric conditions, studied principally for angiogenic signalling through the VEGFR2 pathway. TB-500 is the synthetic analogue of the thymosin beta-4 actin-binding domain, studied for actin monomer sequestration and the cell migration that depends on it. Two mechanisms, one research domain — which is why the pair is so consistently studied together.
The one thing that genuinely differs is an arithmetic trap. Reconstituting a 20 mg vial in the volume you would use for a 10 mg vial doubles the concentration, and unless the draw volume is halved, delivered mass doubles silently. That is worth stating plainly because it is the most common error when switching strengths. Beyond that, the same evidence caveats apply: both literatures are predominantly rodent, neither component has controlled human efficacy data, BPC-157's July 2026 FDA compounding-committee review was an eligibility discussion rather than an approval, and the combination itself has been studied by nobody. New-U Research Compounds supplies this blend as research-grade lyophilised powder with a batch certificate of analysis, strictly for in-vitro and preclinical research use. It is not approved for human therapeutic use in any jurisdiction, and nothing on this page constitutes medical advice or a dosing recommendation.
Customer Reviews
No customer reviews yet — be the first to share your experience.
More in Stacks
BPC+TB 10mg Combo vs related Stacks compounds
Descriptive catalog comparison for research sourcing decisions — not dosing guidance. All compounds are for laboratory research use only.